JKHY
Jack Henry & Associates, Inc.
JKHY's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over JKHY overall, supported by stronger modeled upside and stronger fundamentals.
JKHY Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Strong |
JKHY's profitability, cash flow and balance sheet are currently strong, and its revenue is stable.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
JKHY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $176 | — |
| Current | 24x | $176 | — |
| Cheap | 28x | $201 | +14% |
| Fair | 34x | $250 | +42% |
| Expensive | 42x | $303 | +72% |
Historical ranges are pointers, not guarantees.
JKHY's PE is in its cheap range at 24x. If earnings grow as analysts expect, today's price would be 23x next year's earnings.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over JKHY in the historical PE scenario, which offers more potential upside but is not a forecast.
JKHY Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for JKHY, with profitability improving.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
JKHY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.57 | +3.8% |
| Q3 2026 | $7.29 | +11% |
| Q2 2026 | $6.98 | +12% |
| Q1 2026 | $7.15 | +22% |
| Q4 2025 | $6.96 | +25% |
| Q3 2025 | $6.58 | +20% |
| Q2 2025 | $6.24 | +19% |
| Q1 2025 | $5.88 | +14% |
| Q4 2024 | $5.55 | +8.6% |
JKHY's earnings per share have climbed steadily: $7.29 over the past year, up 11% from the year before, and higher year over year for 12 quarters in a row.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over JKHY on earnings, with stronger typical year-over-year growth.
JKHY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $701.5M | +8.8% |
| Q2 2026 | $644M | +4.7% |
| Q1 2026 | $636.2M | +8.7% |
| Q4 2025 | $619.3M | +7.9% |
| Q3 2025 | $644.7M | +7.3% |
| Q2 2025 | $615.4M | +9.9% |
| Q1 2025 | $585.1M | +8.6% |
| Q4 2024 | $573.8M | +5.2% |
JKHY's revenue has grown year over year every quarter since late 2020: $702M last quarter, up 8.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | +1 points |
| Q2 2026 | 21% | -4.1 points |
| Q1 2026 | 24% | +0.7 points |
| Q4 2025 | 26% | +4.3 points |
| Q3 2025 | 29% | +3.4 points |
| Q2 2025 | 25% | +2.9 points |
| Q1 2025 | 24% | +2.9 points |
| Q4 2024 | 21% | -0.4 points |
JKHY's operating margin was 30% last quarter, up 1 points from the same quarter a year ago, near the top of its range since 2019.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over JKHY on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over JKHY on profitability, with a higher operating margin.
JKHY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $134.3M | +20% |
| Q2 2026 | $282.2M | -10% |
| Q1 2026 | $169.5M | +76% |
| Q4 2025 | $131.4M | +80% |
| Q3 2025 | $111.7M | +7.3% |
| Q2 2025 | $314.9M | +51% |
| Q1 2025 | $96.1M | +9.6% |
| Q4 2024 | $73M | +13% |
JKHY's free cash flow has been positive every quarter for seven years: $717M over the past year, up 20% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over JKHY on cash flow, with stronger typical year-over-year growth.
JKHY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.5% | -1.8M shares |
| 1 year | -3.6% | -2.6M shares |
| 3 years | -3.8% | -2.8M shares |
| 5 years | -5.2% | -3.9M shares |
| Available history | -8.7% | -6.7M shares |
JKHY has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $70.9M |
| Q2 2026 | $163.8M |
| Q1 2026 | $159.2M |
| Q4 2025 | $63.2M |
| Q3 2025 | $62M |
| Q2 2025 | $1,000 |
| Q1 2025 | $18M |
| Q4 2024 | $17.1M |
JKHY spent $457M buying back its own shares over the past year, about five times what it spent the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
JKHY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.0x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.2x | Net Cash |
| Q1 2025 | 0.2x | Very low |
| Q4 2024 | 0.2x | Very low |
JKHY's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
JKHY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.1 | Neutral |
| Stochastic | 70.3 | Neutral |
JKHY's weekly RSI is 63 (neutral) and its Stochastic is 70 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
JKHY PE vs Technology Sector
| Metric | JKHY | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 28x | 13% below |
| PE % | 11 | 35 | 24 pts below |
JKHY is trading at 24x earnings, a 13% discount to the Technology sector's median of 28x.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over JKHY on valuation relative to its sector.
JKHY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $158.3 | 11% above |
| 20 week MA | $157.3 | 12% above |
| 50 week MA | $159.2 | 11% above |
| 100 week MA | $164.7 | 6.9% above |
| 200 week MA | $164.8 | 6.8% above |
JKHY has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
JKHY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $146.6 | $157.7 | +7.6% |
| 2021 | $157.7 | $165.4 | +4.9% |
| 2022 | $165.4 | $177.3 | +7.2% |
| 2023 | $177.3 | $163.4 | -7.9% |
| 2024 | $163.4 | $176.9 | +8.2% |
| 2025 | $176.9 | $186.1 | +5.2% |
| 2026 YTD | $186.1 | $176.0 | -5.4% |
JKHY has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.